Interactions between foodstuffs and statins;Interacciones entre los alimentos y las estatinas

Nutricion Hospitalaria

Volumn 19, Issue 4, 2004, Pages 195-201

  De Andres S ^a   Lucena, A ^a   De Juana, P ^a  

^a HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Food drug interaction; Statins

Indexed keywords

FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PHENOBARBITAL; RIFAMPICIN; SIMVASTATIN; ALCOHOL; FATTY ACID;

DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; FOOD; FOOD DRUG INTERACTION; FOOD INTAKE; HUMAN; HYPERLIPIDEMIA; NUTRIENT; REVIEW; ABSORPTION; BEVERAGE; GRAPEFRUIT; METABOLISM;

CITRUS X PARADISI;

ABSORPTION; BEVERAGES; CITRUS PARADISI; ETHANOL; FATTY ACIDS; FOOD-DRUG INTERACTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 16644372059     PISSN: 02121611     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Yamreudeewong W, Henann NE, Fazio A: Drug-food interactions in clinical practice. J Family Pract 1995, 40:376-84.
2. Chen LH, Liu S, Cook N y cols.: Survey of drug use by the elderly and possible impact of drugs in nutritional status. Drug-Nutr Interact 1985, 3:73-86.
3. Medina V: Recomendaciones Farmacéuticas sobre el uso de medicamentos de administración oral. Rev OFIL 1994, 4:289-99.
4. Winstanley PA, Orne MLE: The effects of food on drug bioavailability. Br J Clin Pharmacol 1989, 28:621-8.
5. Mariné A, Vidal MC, Codony R: Interacciones entre fármacos y alimentos. En: Nutrición y Dietética. Aspectos sanitarios. Edita: Consejo General de Colegios Oficiales de Farmacéuticos. Gráficas Gispert. La Bisbal (Gerona). 1991, 903-957.
6. Lohezic-Le Devehat F, Marigny K, Doucet M, Javaudin L: Grapefruit juice and drugs: a hazardous combination? Therapie 2002, 57:432-45.
7. Krishnaswamy K: Effects of malnutrition on drug metabolism and Toxicity in humans. En: Hatchcock JN, (Ed.) Nutritional Toxicology. Nueva York. Academic Press. Inc 1987, 105-28.
8. Abernethy DR, Greeblatt DJ: Drug disposition in obese humans: an update. Clin Pharmacokinet 1986, 11:199-213.
9. Welling PG, Koch PA, Lau CC y cols.: Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects. Antimicrob Agents Chemother 1977, 11:462-69.
10. Neuvonen PJ, MD, Kivistö KT, Lehto P: Interference of dairy products with the absortion of ciprofloxacin. Clin Pharmacol Ther 1991, 50:498-502.
11. Zimmermann T, Yeates RA, Laufen H y cols.: Influence of concomitant food intake on the oral absortion of two tiaxole antifungical agents, itraconazole and fluconazole. Eur J Clin Pharmacol 1994, 46:147-50.
12. Gilman AG, Rall TW, Nies AS y cols. (eds.): Goodman and Gilmam's The Pharmacological Basis of Therapeutics (8 ed.). Nueva York. Pergamon Press, 1990.
13. Eriksson T, Granerus AK, Linde A y cols.: On-Off phenomenon in Parkinson disease: relationship between dopa and other large neutral acids in plasma. Neurology 1988, 38:1245-48.
14. Finn A, Straug A, Meyer M, Chubb J: Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm Drug Dispos 1987, 8:519-26.
15. Overdiek HW, Merkus FW: Influence of food on the bioavaliability of spironolactone. Clin Pharmacol Ther 1986, 40:531-6.
16. Van Peer A, Woestrenborghs R, Heykants J y cols.: The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. Eur J Clin Pharmacol 1989, 36:423-26.
17. Krishnaswamy K: Drug metabolism and pharmacokinetics in malnourished children. Clin Pharmacokinet 1989, 17(Suppl. 1):68-88.
18. Abernethy DR, Greeblatt DJ: Drug disposition in obese humans: an update. Clin Pharmacokinet 1986, 11:199-213.
19. Fagan TC, Walle T, Oexmann MJ y cols.: Increased clerance of propanolol and theophylline by high-protein compared with high-carbohydrate diet. Clin Pharmacol Ther 1987, 41:402-406.
20. Álvarez de Sotomayor M, Herrera MD, Pérez-Guerrero C, Marhuenda E: Interés terapéutico de las estatinas en el tratamiento de la arterioesclerosis. Ars Pharmaceutica, 1999, 40:4,217-31.
21. Stein DT, Devaraj S, Balis D y cols.: Effect of statin therapy on remnant lipoprotein cholesterol levels in patient with combined hyperlipidemia. Arterioesclerosis, thrombosis and vascular Biology 2001, 21:2026-2031.
22. Alberts AW: HMG-Co A reductase inhibitors-the developement. Atherosclerosis Rev 1998, 18:123-131.
23. Nota informativa de la Agencia Española del Medicamento sobre Cerivastatina y casos de rabdomiolisis. Mayo 2001.
24. Herman RJ: Drug interation the statins. CMAJ 1999, 161:1281-6.
25. Maron DJ, Fazio S, Linton MF: Current perspectives on satitns. Circulation 2000, 101:207-13.
26. Horsmans Y: Metabolismo diferencial de las estatinas. European Heart Journal Supplements 1999, 1:T7-T12.
27. Moghadasian MH: Clynical pharmacology of 3-hidroxy 3-methyglutaryl coenzyme A reductase. Life Sci 1999, 65:1329-37.
28. Bell LP, Hectorn KJ, Reynols H, Hunninghake DB: Cholesterol-lowering effects of solublefiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemia. Am J Clin Nutr 1990, 52:1020-26.
29. Davidson MH, Dugan LD, Burns JH y cols.: The hypocholesterolemic effects of B-glucan in oatmeal and oat bran. JAMA 1991, 265:1833-39.
30. Richter WO, Jacobs BG, Schwandt P: Interacction between fibre and lovastatin. The Lancet 1991, 338:706.
31. Radulovic LL, Cilla DD, Posvar EL y cols.: Effect of food on the bioavailability of atorvastatin, and HMG CoA reductase inhibitor. J Clin Pharmacol 1995, 35(10):990-4.
32. Kane GC, Lipsky JJ: Drug-grapefruit juice interactions. Mayo Clin Proc 2000, 75:933-42.
33. Lilja JJ, Kivisto KT, Neuvonen PJ: Grapeffruit juice-simvastatin interaction: effect on serum concentrations of simbastatin, simvastatin acid, and HMG CoA reductase inhibitors. Clin Pharmacol Ther 1998, 64(5):477-83.
34. Kantola T, Kivisto KT, Neuvonen PJ: Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1998, 63(4):397-402.
35. Antti Jula, Jukka Marniemi, Risto Huupponem y cols.: Effects of diet and Simvastatin on Serum lipids, Insulin, and Antioxidants in Hypercholesterolemic Men. JAMA 2002, 287:598-605.
36. Smit JW, Wijnne HJ, Schobben F y cols.: Effects of alcohol and fluvastatin on lipid metabolism and hepatic function. Ann Intern Med 1995, 122(9):678-80.